wills eye hospital leads research for recently fda-approved treatment for eye disease, macular degen
Published 2 years ago • 444 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
4:02
drs rapuano and nagra of wills eye hospital discuss the fda approval of xiidra
-
4:42
wills eye patient story
-
3:56
glaucoma overview - wills eye hospital
-
0:53
wills eye hospital #1 ophthalmology residency in america
-
6:19
long-term data testing treatment in patients with thyroid eye disease
-
2:40
aao 2022. wills eye retina highlights
-
10:59
thyroid eye disease - thyroid treatment
-
11:13
thyroid eye disease - consultation & investigation
-
10:58
how long thyroid eye disease/graves disease lasts, and reducing eye prominence
-
3:37
wills eye overview 2014
-
5:19
douglas m. wisner, md - wills eye hospital
-
3:24
the pemphigoid clinic at wills eye hospital
-
2:43
inside wills eye hospital during covid-19
-
9:09
why wills eye?
-
54:13
wills eye hospital ophthalmology allstars 3/29/17
-
2:25
wills eye hospital - moving forward to care for our patients
-
0:50
invitation to 74th annual wills eye hospital conference by conference chair sunir j. garg, md.
-
5:25
thyroid eye disease - 15. after surgery
-
1:03
thyroid eye disease - 14. lid surgery - the operation
-
1:03
spotlight on thyroid eye disease
-
1:20
thyroid thursday - treating asian patients with thyroid eye disease